Feeling Sick? Act Quick! This BinaxNOW™ COVID-19 Antigen Self Test is a convenient, 2-count pack. This rapid antigen test from Abbott detects active COVID-19 infection in adults and kids as young as 2 years old. FDA authorized, 15-minute rapid COVID-19 self test delivers reliable results. It utilizes the same technology used by doctors to test for COVID-19. Test Kit Contains: 2 Test Cards, 2 Swabs, 2 Dropper Bottles and instructions for use.
BinaxNOW™ 2-Test Pack: This double-pack includes 2 at-home tests designed to detect active infection.
BinaxNOW™ Self Test uses THE SAME TECHNOLOGY USED BY DOCTORS to test for COVID-19.
Detects multiple COVID-19 variants, including Delta and Omicron*
FDA Authorized 15-Minute Self Test: Convenient COVID-19 at-home test provides fast, reliable results in 15 minutes, results anytime, anywhere; no need for a prescription or to send to a lab.
Reliable and Easy-to-Use: Requires just a shallow nasal swab that you can do yourself; includes easy-to-follow instructions.
For Ages 2 and Above: COVID test suitable for kids, when administered by an adult, and for all people 15 and older to self-administer.
Detects Active COVID-19 infection: Includes 2 rapid tests that are indicated for serial testing. Serial (or repeat) testing should be performed in individuals with negative results at least twice over three days (with at least 48 hours between tests) for symptomatic individuals and three times over five days (with at least 48 hours between tests) for asymptomatic individuals.
Expiration Date Extension: On December 21, 2022, the FDA granted BinaxNOW™ COVID-19 Self Test 15 month to 22 month shelf-life extension. Please refer to to look up extended dating by lot number. Or visit the FDA website for the detailed list of extended expiration dates by lot numbers:
*Abbott conducted an analysis of the detection of multiple SARS-COV-2 strains and predicts no impact to the performance of our BinaxNOW COVID-19 Antigen Self Test.
The BinaxNOW™ COVID-19 Antigen Self Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARSCoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
